琥珀酰化
生物化学
癌症
赖氨酸
细胞生物学
医学
生物
氨基酸
内科学
出处
期刊:Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2022-11-11
卷期号:101 (45): e31493-e31493
被引量:6
标识
DOI:10.1097/md.0000000000031493
摘要
Lysine succinylation is a novel, broad-spectrum, dynamic, non-enzymatic protein post-translational modification (PTM). Succinylation is essential for the regulation of protein function and control of various signaling and regulatory pathways. It is involved in several life activities, including glucose metabolism, amino acid metabolism, fatty acid metabolism, ketone body synthesis, and reactive oxygen species clearance, by regulating protease activity and gene expression. The level of succinylation is mainly regulated by succinyl donor, succinyltransferase, and desuccinylase. Many studies have confirmed that succinylation plays a role in tumorigenesis by creating tissue heterogeneity, and can promote or inhibit various cancers via the regulation of different substrate targets or signaling pathways. The mechanism of action of some antineoplastic drugs is related to succinylation. To better understand the role of succinylation modification in cancer development and treatment, the present study reviewed the current research content and latest progress of succinylation modification in cancer, which might provide a new direction and target for the prevention and treatment of cancer.
科研通智能强力驱动
Strongly Powered by AbleSci AI